Commonwealth Equity Services, LLC Essa Pharma Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$7.76 - $29.37 $226,553 - $857,457	-29,195 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$11.61 - $32.08 $1,161 - $3,208	-100 Reduced 0.34%	29,195 $848,000
Q3 2020 Nov 05, 2020	BUY	$6.0 - $7.79 $30,150 - $39,144	5,025 Added 20.7%	29,295 $202,000
Q2 2020 Aug 12, 2020	BUY	$3.71 - $6.2 $12,057 - $20,150	3,250 Added 15.46%	24,270 $150,000
Q4 2019 Feb 05, 2020	BUY	$3.05 - $6.0 $29,036 - $57,120	9,520 Added 82.78%	21,020 $115,000
Q3 2019 Oct 30, 2019	BUY	$1.46 - $3.37 $16,790 - $38,755	11,500 New	11,500 $38,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.